Home

suc țarc Tragic carta 2005 levodopa fault Fără sens cădere brusca

Evaluation of Levodopa Dose and Magnitude of Dopamine Depletion as Risk  Factors for Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's  Disease | Journal of Pharmacology and Experimental Therapeutics
Evaluation of Levodopa Dose and Magnitude of Dopamine Depletion as Risk Factors for Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease | Journal of Pharmacology and Experimental Therapeutics

PDF) Profile of levodopa/carbidopa intestinal gel and its potential in the  treatment of advanced Parkinson's disease
PDF) Profile of levodopa/carbidopa intestinal gel and its potential in the treatment of advanced Parkinson's disease

Biomolecules | Free Full-Text | Treatment Options for Motor and Non-Motor  Symptoms of Parkinson's Disease | HTML
Biomolecules | Free Full-Text | Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease | HTML

Frontiers | The Human Experience with Intravenous Levodopa
Frontiers | The Human Experience with Intravenous Levodopa

PDF) Lowered cAMP and cGMP signalling in the brain during levodopa-induced  dyskinesias in hemiparkinsonian rats: New aspects in the pathogenetic  mechanisms
PDF) Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: New aspects in the pathogenetic mechanisms

Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of  Parkinson's Disease
Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson's Disease

Frontiers | A Multi-Scale Computational Model of Levodopa-Induced Toxicity  in Parkinson's Disease
Frontiers | A Multi-Scale Computational Model of Levodopa-Induced Toxicity in Parkinson's Disease

Frontiers | Histological Correlates of Neuroanatomical Changes in a Rat  Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry
Frontiers | Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry

Review: Therapeutic options for continuous dopaminergic stimulation in  Parkinson's disease
Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease

Levodopa-induced dyskinesias in patients with Parkinson's disease: filling  the bench-to-bedside gap - The Lancet Neurology
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap - The Lancet Neurology

Eltoprazine prevents levodopa-induced dyskinesias by reducing causal  interactions for theta oscillations in the dorsolateral striatum and  substantia nigra pars reticulate - ScienceDirect
Eltoprazine prevents levodopa-induced dyskinesias by reducing causal interactions for theta oscillations in the dorsolateral striatum and substantia nigra pars reticulate - ScienceDirect

Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes  on behavior of dyskinesia rats
Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats

Impairment of neuronal mitochondrial function by l-DOPA in the absence of  oxygen-dependent auto-oxidation and oxidative cell damage | Cell Death  Discovery
Impairment of neuronal mitochondrial function by l-DOPA in the absence of oxygen-dependent auto-oxidation and oxidative cell damage | Cell Death Discovery

PDF) Mechanisms underlying the onset and expression of levodopa-induced  dyskinesia and their pharmacological manipulation
PDF) Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation

Frontiers | Mathematical Insights into the Effects of Levodopa
Frontiers | Mathematical Insights into the Effects of Levodopa

Lowered cAMP and cGMP signalling in the brain during levodopa‐induced  dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic  mechanisms - Giorgi - 2008 - European Journal of Neuroscience - Wiley  Online Library
Lowered cAMP and cGMP signalling in the brain during levodopa‐induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms - Giorgi - 2008 - European Journal of Neuroscience - Wiley Online Library

Brain Sciences | Free Full-Text | Transcriptome Sequencing Reveal That  Rno-Rsf1_0012 Participates in Levodopa-Induced Dyskinesia in  Parkinson’s Disease Rats via Binding to Rno-mir-298-5p | HTML
Brain Sciences | Free Full-Text | Transcriptome Sequencing Reveal That Rno-Rsf1_0012 Participates in Levodopa-Induced Dyskinesia in Parkinson’s Disease Rats via Binding to Rno-mir-298-5p | HTML

L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the  striatum | Scientific Reports
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum | Scientific Reports

Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of  Parkinson's Disease | eNeuro
Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson's Disease | eNeuro

Studies of the Rate Constant of Levodopa Methyl Ester Hydrolysis by LC
Studies of the Rate Constant of Levodopa Methyl Ester Hydrolysis by LC

A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars  Compacta in Parkinson's Disease
A Computational Model of Levodopa-Induced Toxicity in Substantia Nigra Pars Compacta in Parkinson's Disease

Therapeutic strategies for Parkinson's disease: promising agents in early  clinical development
Therapeutic strategies for Parkinson's disease: promising agents in early clinical development

Concomitant short‐ and long‐duration response to levodopa in the  6‐OHDA‐lesioned rat: a behavioural and molecular study - Marin - 2007 -  European Journal of Neuroscience - Wiley Online Library
Concomitant short‐ and long‐duration response to levodopa in the 6‐OHDA‐lesioned rat: a behavioural and molecular study - Marin - 2007 - European Journal of Neuroscience - Wiley Online Library

PDF) Continuous levodopa for advanced Parkinson's disease
PDF) Continuous levodopa for advanced Parkinson's disease